{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:42:25Z","timestamp":1792384945190,"version":"4.4.0"},"reference-count":41,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Taisho Pharmaceutical Co."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>In recent years, sarcopenic obesity has been considered central pathological factors in diabetes. This study aimed to compare the effect of luseogliflozin, a sodium-glucose co-transporter-2 inhibitor (SGLT2i), on sarcopenic obesity in comparison to that of a low-carbohydrate diet (LCD). Twenty-week-old male db\/db mice were fed a normal diet (Ctrl), LCD, and normal diet with 0.01% w\/w luseogliflozin (SGLT2i) for eight weeks. Skeletal muscle mass and grip strength decreased in the LCD group mice compared to those in the control group, while they increased in the SGLT2i group mice. The amino acid content in the liver, skeletal muscle, and serum were lower in the LCD group than those in the Ctrl group but increased in the SGLT2i group mice. Short-chain fatty acids in rectal feces were lower in the LCD group mice than those in the Ctrl group, whereas they were higher in the SGLT2i group mice. The abundance of Gammaproteobacteria, Enterobacteriaceae, Escherichia, Enterobacterales, and Bacteroides caccae species increased in the LCD group compared to the other two groups, whereas the abundance of Syntrophothermus lipocalidus, Syntrophomonadaceae family, Parabacteroidesdistasonis distasonis, and the genus Anaerotignum increased in the SGLT2i group. Luseogliflozin could prevent sarcopenic obesity by improving amino acid metabolism.<\/jats:p>","DOI":"10.3390\/nu14173531","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T22:53:42Z","timestamp":1661813622000},"page":"3531","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db\/db Mice"],"prefix":"10.3390","volume":"14","author":[{"given":"Shinnosuke","family":"Hata","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7269-1697","authenticated-orcid":false,"given":"Takuro","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Bamba","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"},{"name":"Department of Endocrinology, Diabetes and Metabolism, Kyoto Chubu Medical Center, Nantan 629-0197, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1537-326X","authenticated-orcid":false,"given":"Tomoki","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3209-1790","authenticated-orcid":false,"given":"Hanako","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8794-0550","authenticated-orcid":false,"given":"Yoshitaka","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"},{"name":"Department of Diabetology, Matsushita Memorial Hospital, Moriguchi 570-8540, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Majima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Senmaru","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1707-970X","authenticated-orcid":false,"given":"Hiroshi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1031-4380","authenticated-orcid":false,"given":"Emi","family":"Ushigome","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takakuwa","sequence":"additional","affiliation":[{"name":"Agilent Technologies, Chromatography Mass Spectrometry Sales Department, Life Science and Applied Markets Group, Hachioji 192-0033, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Sasano","sequence":"additional","affiliation":[{"name":"AiSTI Science Co., Ltd., Wakayama 640-8390, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-4445","authenticated-orcid":false,"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-1797","authenticated-orcid":false,"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Osaka, T., Hashimoto, Y., Okamura, T., Fukuda, T., Yamazaki, M., Hamaguchi, M., and Fukui, M. (2019). Reduction of Fat to Muscle Mass Ratio Is Associated with Improvement of Liver Stiffness in Diabetic Patients with Non-Alcoholic Fatty Liver Disease. J. Clin. Med., 8.","DOI":"10.3390\/jcm8122175"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3164\/jcbn.18-114","article-title":"The sodium glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db\/Db mice by suppressing the expression of foxo1","volume":"65","author":"Okamura","year":"2019","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/jcsm.12814","article-title":"Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db\/db mice","volume":"13","author":"Bamba","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.celrep.2016.09.047","article-title":"High-Protein Intake during Weight Loss Therapy Eliminates the Weight-Loss-Induced Improvement in Insulin Action in Obese Postmenopausal Women","volume":"17","author":"Smith","year":"2016","journal-title":"Cell Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.7326\/0003-4819-158-6-201303190-00588","article-title":"Vitamin D and calcium supplementation to prevent fractures in adults: U.S. preventive services task Force recommendation statement","volume":"158","author":"Moyer","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nut.2014.06.011","article-title":"Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base","volume":"31","author":"Feinman","year":"2015","journal-title":"Nutrition"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"662591","DOI":"10.3389\/fendo.2021.662591","article-title":"The Potential Roles of Very Low Calorie, Very Low Calorie Ketogenic Diets and Very Low Carbohydrate Diets on the Gut Microbiota Composition","volume":"12","author":"Rondanelli","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/S2468-2667(18)30135-X","article-title":"Dietary carbohydrate intake and mortality: A prospective cohort study and meta-analysis","volume":"3","author":"Seidelmann","year":"2018","journal-title":"Lancet Public Health"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1017\/S0007114516002178","article-title":"Impact of low-carbohydrate diet on renal function: A meta-analysis of over 1000 individuals from nine randomised controlled trials","volume":"116","author":"Oyabu","year":"2016","journal-title":"Br. J. Nutr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-7075-3-9","article-title":"Very-low-carbohydrate diets and preservation of muscle mass","volume":"3","author":"Manninen","year":"2006","journal-title":"Nutr. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"19652","DOI":"10.1038\/s41598-019-56166-8","article-title":"Ketogenic diet induces skeletal muscle atrophy via reducing muscle protein synthesis and possibly activating proteolysis in mice","volume":"9","author":"Nakao","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AEM.02340-06","article-title":"Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces","volume":"73","author":"Duncan","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/ijo.2008.155","article-title":"Human colonic microbiota associated with diet, obesity and weight loss","volume":"32","author":"Duncan","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3945\/ajcn.110.002188","article-title":"High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health","volume":"93","author":"Russell","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/MIB.0000000000000750","article-title":"Current Understanding of Dysbiosis in Disease in Human and Animal Models","volume":"22","author":"Degruttola","year":"2016","journal-title":"Inflamm. Bowel. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/s41467-020-18262-6","article-title":"Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity","volume":"11","author":"Yang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"bvz039","DOI":"10.1210\/jendso\/bvz039","article-title":"Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development","volume":"4","author":"Ghosh","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbrc.2015.10.109","article-title":"Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic \u03b2-cells in obese type 2 diabetic db\/db mice","volume":"470","author":"Okauchi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/dom.13400","article-title":"Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic \u03b2-cells in db\/db mice: The earlier and longer, the better","volume":"20","author":"Kimura","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kawano, R., Okamura, T., Hashimoto, Y., Majima, S., Senmaru, T., Ushigome, E., Asano, M., Yamazaki, M., Takakuwa, H., and Sasano, R. (2021). Erythritol ameliorates small intestinal inflammation induced by high-fat diets and improves glucose tolerance. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115558"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"669672","DOI":"10.3389\/fimmu.2021.669672","article-title":"Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance","volume":"12","author":"Okamura","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"9749","DOI":"10.1038\/s41598-018-28126-1","article-title":"A taxonomic signature of obesity in a large study of American adults","volume":"8","author":"Peters","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Guh, D.P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C.L., and Anis, A.H. (2009). The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health, 9.","DOI":"10.1186\/1471-2458-9-88"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s42255-020-0178-9","article-title":"Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity","volume":"2","author":"Jensen","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1099\/00207713-50-2-771","article-title":"Syntrophothermus lipocalidus gen. nov., sp. nov., a novel thermophilic, syntrophic, fatty-acid-oxidizing anaerobe which utilizes isobutyrate","volume":"50","author":"Sekiguchi","year":"2000","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1128\/AEM.00190-11","article-title":"Syntrophomonadaceae-affiliated species as active butyrate-utilizing syntrophs in paddy field soil","volume":"77","author":"Liu","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1099\/ijsem.0.002268","article-title":"Description of Anaerotignum aminivorans gen. nov., sp. nov., a strictly anaerobic, amino-acid-decomposing bacterium isolated from a methanogenic reactor, and reclassification of Clostridium propionicum, Clostridium neopropionicum and Clostridium lactatifermentans as species of the genus Anaerotignum","volume":"67","author":"Ueki","year":"2017","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-Repiso, C., Molina-Vega, M., Bernal-L\u00f3pez, M.R., Garrido-S\u00e1nchez, L., Garc\u00eda-Almeida, J.M., Sajoux, I., Moreno-Indias, I., and Tinahones, F.J. (2021). Different Weight Loss Intervention Approaches Reveal a Lack of a Common Pattern of Gut Microbiota Changes. J. Pers. Med., 11.","DOI":"10.3390\/jpm11020109"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12934-020-01319-y","article-title":"Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children","volume":"19","author":"Bikel","year":"2020","journal-title":"Microb. Cell. Fact."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.2174\/1381612824666180912143434","article-title":"Effect of Dapagliflozin on Intestinal Flora in MafA-deficient Mice","volume":"24","author":"Li","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.diabet.2019.11.005","article-title":"Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes","volume":"46","author":"Herrema","year":"2020","journal-title":"Diabetes Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"F824","DOI":"10.1152\/ajprenal.00314.2017","article-title":"Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model","volume":"315","author":"Mishima","year":"2018","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nm.3779","article-title":"Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes","volume":"21","author":"Tang","year":"2015","journal-title":"Nat. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.2337\/db14-1938","article-title":"GPR43 Potentiates \u03b2-Cell Function in Obesity","volume":"64","author":"McNelis","year":"2015","journal-title":"Diabetes"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Okamura, T., Hamaguchi, M., Mori, J., Yamaguchi, M., Mizushima, K., Abe, A., Ozeki, M., Sasano, R., Naito, Y., and Fukui, M. (2022). Partially Hydrolyzed Guar Gum Suppresses the Development of Sarcopenic Obesity. Nutrients, 14.","DOI":"10.3390\/nu14061157"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.cell.2014.11.034","article-title":"Metabolic inflexibility: When mitochondrial indecision leads to metabolic gridlock","volume":"159","author":"Muoio","year":"2014","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/dia.2013.0167","article-title":"Changes in insulin sensitivity and insulin secretion with the sodium glucose cotransporter 2 inhibitor dapagliflozin","volume":"16","author":"Mudaliar","year":"2014","journal-title":"Diabetes Technol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1210\/jc.2008-2216","article-title":"Changes in basal and insulin and amino acid response of whole body and skeletal muscle proteins in obese men","volume":"94","author":"Guillet","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/BJ20120772","article-title":"A novel PKB\/Akt inhibitor, MK-2206, effectively inhibits insulin-stimulated glucose metabolism and protein synthesis in isolated rat skeletal muscle","volume":"447","author":"Lai","year":"2012","journal-title":"Biochem. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI88880","article-title":"Skeletal muscle inflammation and insulin resistance in obesity","volume":"127","author":"Wu","year":"2017","journal-title":"J. Clin. Investig."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/17\/3531\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:16:22Z","timestamp":1760141782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/17\/3531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,27]]},"references-count":41,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["nu14173531"],"URL":"https:\/\/doi.org\/10.3390\/nu14173531","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,27]]}}}